Data updated: Mar 10, 2026
POLYMYXIN B SULFATE
POLYMYXIN B SULFATE
Approved 1964-06-29
7
Indications
--
Phase 3 Trials
61
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1964-06-29
- Routes
- INJECTION, FOR RX COMPOUNDING
- Dosage Forms
- INJECTABLE, POWDER
POLYMYXIN B SULFATE Approval History
Loading approval history...
What POLYMYXIN B SULFATE Treats
7 FDA approvalsOriginally approved for its first indication in 1964 . Covers 7 distinct patient populations.
- Other (7)
Other
(7 approvals)- • Approved indication (Jun 1964)
- • Approved indication (Sep 1994)
- • Approved indication (Jan 2008)
- • Approved indication (Jun 2011)
- • Approved indication (Jan 2014)
- • Approved indication (Apr 2016)
- • Approved indication (Apr 2016)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
POLYMYXIN B SULFATE FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.